Argent Capital Management LLC increased its position in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 16.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,812 shares of the company’s stock after acquiring an additional 6,555 shares during the period. Argent Capital Management LLC’s holdings in Addus HomeCare were worth $5,743,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in the company. Wasatch Advisors LP raised its holdings in Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after acquiring an additional 110,010 shares during the period. Point72 Asset Management L.P. raised its stake in Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares in the last quarter. State Street Corp grew its holdings in Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock valued at $88,280,000 after buying an additional 27,990 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Stock Up 2.1 %
Shares of NASDAQ:ADUS opened at $131.27 on Thursday. The business’s 50 day moving average is $125.07 and its 200 day moving average is $126.29. The stock has a market cap of $2.38 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.12.
Insiders Place Their Bets
In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,750 shares of company stock worth $4,930,750 over the last 90 days. Company insiders own 4.60% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have issued reports on ADUS shares. Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. JMP Securities initiated coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Finally, StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $133.67.
Get Our Latest Research Report on Addus HomeCare
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Insider Trades May Not Tell You What You Think
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- How to Read Stock Charts for Beginners
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
- What is MarketRankā¢? How to Use it
- D-Wave’s Stock Springs Back in the Quantum Computing Race
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.